Clinical Trials Directory

Trials / Terminated

TerminatedNCT00395603

Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)

Compare Ezetimibe 10mg and Simvastatin 40mg vs Atorvastatin 80mg Daily in Subjects With Cardiovascular Heart Disease and/or Diabetes Mellitus With Uncontrolled Lipids on Statin Therapy

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
550 (estimated)
Sponsor
Organon and Co · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare the effectiveness of ezetimibe/simvastatin 10/40 daily to atorvastatin 80 daily in reducing the concentration of ldl-c at endpoint after 6 weeks of treatment.

Conditions

Interventions

TypeNameDescription
DRUGMK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks
DRUGComparator: atorvastatin / Duration of Treatment: 6 Weeks

Timeline

Start date
2006-09-01
Primary completion
2007-06-01
Completion
2007-06-01
First posted
2006-11-03
Last updated
2024-08-15

Source: ClinicalTrials.gov record NCT00395603. Inclusion in this directory is not an endorsement.

Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122) (NCT00395603) · Clinical Trials Directory